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ABSTRACT: Back arching was reported in one of
the very first patients with neurodegeneration with brain
iron accumulation syndrome (NBIAs) published in 1936.
However, recent reports have mainly focused on the
genetic and imaging aspects of these disorders, and the
phenotypic characterization of the dystonia has been
lost. In evaluating patients with NBIAs in our centers, we
have observed that action-induced dystonic opisthoto-
nus is a common and characteristic feature of NBIAs.
Here, we present a case series of patients with NBIAs
presenting this feature demonstrated by videos. We sug-
gest that dystonic opisthotonus could be a useful “red
flag” for clinicians to suspect NBIAs, and we discuss the
differential diagnosis of this feature. This would be partic-
ularly useful in identifying patients with NBIAs and no iron
accumulation as yet on brain imaging (for example, as
in phospholipase A2, group IV (cytosolic, calcium-
independent) [PLA2G6]-related disorders), and it has
management implications. VC 2013 International Parkinson
and Movement Disorder Society
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With the advent in genetics, a variety of complicated
recessive dystonia syndromes have been identified, and
the similarity in their clinical presentations makes the
differential diagnosis for clinicians diffi-
cult.1,2 Hence, clinical clues and “red flags” may be
an important help. Generally, in the differential diag-
nosis of dystonia, the phenomenology, the distribution
combined with the age of onset, and the presence of
other features are of great importance. For example,
lower limb dystonia in an adult is a clue for second-
ary/heredo-degenerative dystonia rather than primary
dystonia. Moreover, severe oromandibular dystonia
points to certain disorders, such as neuroacanthocyto-
sis, neuroleptic drug-induced dystonia, neurodegenera-
tion with brain iron accumulation syndromes (NBIAs),
or Lesch-Nyhan. Much less has been written about
the diagnostic value and differential diagnosis of ex-
tensor truncal dystonia (or dystonic opisthotonus).
NBIAs cause complicated dystonia syndromes and
are characterized by excessive iron deposition in the
brain, particularly affecting the basal ganglia and
mainly the globus pallidus. The 2 core NBIAs are the
neuroaxonal dystrophies pantothenate kinase (PKAN)-
associated and phospholipase A2, group IV (cytosolic,
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calcium-independent) (PLA2G6)-associated neurode-
generation (PLAN), whereas additional disorders
recently have been described.3–5 In evaluating patients
with NBIAs in our centers, we have observed typical
action-induced dystonic opisthotonus, in which the
trunk tends to arch backward when the patient stands
and occasionally even when lying down and attempting
to move. Here, we discuss the differential diagnosis of
dystonic opisthotonus and the occurrence of this feature
in NBIAs. We wish to highlight that dystonic opisthoto-
nus may be a clinical clue that, together with other signs
(such as oromandibular dystonia), should raise suspi-
cion to test for these disorders.
How Common is Dystonic Opisthotonus in
NBIAs?
Numerous early and later case reports, in which
clinical descriptions are detailed, describe neck arching
and back arching in NBIAs6–12; in fact, back arching
was noted in 1 of the very first described patients with
this syndrome published in 1936 by Ludo von
Bogaert.6,7 This confirms that dystonic opisthotonus
may be a common feature of NBIAs. In most of those
early described patients, opisthotonus tended to wor-
sen with action and was observed mostly with young-
onset forms13–17; this is not surprising, because gener-
alized and/or truncal dystonia is more common in
young-onset rather than atypical later-onset cases of
NBIAs.18 Opisthotonus in neuroferritinopathy and
aceruloplasminaemia, which typically have a later age
of onset than PKAN and PLAN, has not been reported
to the best of our knowledge. This may be related to
the later age at onset and also to genetic factors.
A brief review of more recent literature on NBIAs
reveals that, in large series of patients that were pub-
lished mostly after the identification of causative
genes, although generalized, truncal and neck dystonia
are described, and a more specific phenotypic descrip-
tion of the dystonia is largely missing.6,11–17 For
example, 87% of 52 patients with panthothenate ki-
nase 2 (PANK2) mutations had dystonia, including
action-induced axial dystonia, but it is unknown how
many patients had extensor axial dystonia19; in the
largest series of deep brain stimulation in 23 patients
with NBIAs, the dystonia characteristics were not
provided.11,20
We retrospectively evaluated all patients with NBIAs
who have been seen at our center (London) the last 5
years (N5 8) and observed dystonic opisthotonus in 4
of 5 of patients with PANK2 and PLA2G6 mutations
(see video segments 1–3), but not in patients with neu-
roferritinopathy or aceruloplasminaemia (N53),
which is consistent with the literature, as mentioned
above. Detailed clinical descriptions and imaging and
genetic findings in these patients with opisthotonus
have been published elsewhere but are summarized
briefly in the video legend.5,21,22 There are some inter-
esting aspects of these patients highlighted here. First,
in most patients, the dystonic opisthotonus is action-
induced, for example, when the patient stands up and
starts walking (video segments 1, 3, and 4); (Figure 1)
whereas, in Patient 2, this also may occur spontane-
ously while lying down. Second, Patients 3 and 4 did
not have iron on brain magnetic resonance imaging
(MRI) studies (including T2* sequences) or severe oro-
mandibular dystonia, and the clinical clue to test for
NBIAs, in fact, was the dystonic opisthotonus, which
highlights the importance of this sign in the differen-
tial diagnosis. However, the true prevalence of dys-
tonic opisthotonus in NBIAs needs to be assessed in
larger case series.
Differential Diagnosis of Dystonic
Opisthotonus
The differential diagnosis of dystonic opisthotonus
includes mainly secondary dystonias,23–25 while it is
uncommon in primary dystonia.26 Classically, retro-
collis has been described in tardive dystonia caused by
use of dopamine receptor antagonists; approximately
36% to 50% of patients with tardive dystonia have
retrocollis, and about half of these also have extensor
FIG. 1. Photographs show (A) action-induced opisthotonus that occurs when sitting up from bed (Patient 1, PANK2 mutations); (B) spontaneous,
painful retrocollis and dystonic opisthotonus (Patient 2, PANK2 mutations); (C) dystonic opisthotonus while walking (Patient 3, PLA2G6 mutations);
and (D) retrocollis (Patient 4, PLA2G6 mutations).
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truncal dystonia,23,27,28 which worsens during move-
ment, especially walking.23,27–29
Because Wilson’s disease is a common differential
diagnosis in patients with young-onset dystonia syn-
dromes, we screened 100 patients who had sympto-
matic neurologic Wilson’s disease who were followed
in the Wilson’s disease clinic (Kokilaben Dhirubhai
Ambani Hospital, Mumbai, India) for retrocollis and
opisthotonus. We reviewed the medical records and
serial videos that were taken at approximately 3-
month intervals over the last 7 years. Consistent with
other reports,30 axial symptoms related to dystonia
were observed, and some patients presented with ex-
tensor truncal dystonia.
In patients diagnosed with dystonic cerebral palsy,
opisthotonus has been described occasionally, but some
patients with so-called cerebral palsy may have other
conditions (including NBIAs)7,33–36; thus, “red flags”
are important to avoid long delays in diagnosis.31–34
Opisthotonus also has been described in neurometa-
bolic disorders (eg, glutaric aciduria, maple syrup urine
disease, Lesch-Nyhan, dopa-responsive dystonias)33,35–
40 (Table 1). The very early age at onset, delayed motor
milestones, truncal hypotonia, encephalopathic crisis,
and intermittent painful dystonic posturing exacerbated
by fever or infections are helpful clues to suspect a neu-
rometabolic disease (see Table 1).39,41 Conditions that
reportedly cause back arching because of different etiol-
ogies, such as tetanus, strychnine poisoning, meningitis,
and encephalitis, or “arc-de-cercle” in psychogenic dys-
tonia are less likely to pose differential diagnostic prob-
lems with NBIAs.35,42–46
Which Is the Possible Pathophysiology?
The pathophysiologic explanation of the anatomic
predilection for oromandibular and extensor truncal
dystonia in these patients, as opposed to primary dys-
tonias, remains unknown.47 However, the fact that
these features also are present in patients with NBIAs
in whom brain imaging does not show iron deposition
implies that the clinical picture probably is not directly
related to the iron but is related to the underlying neu-
rodegeneration.5,48,49 This is supported by the fact
that treatment with an iron-chelator, deferiprone,
reduced iron in MRI studies but did not improve clini-
cal symptoms.49 Moreover, the finding that dystonic
opisthotonus responds to globus pallidus internus or
subthalamic nucleus deep brain stimulation11,15,50
and, in some patients, also to levodopa22confirms that
it is related to basal ganglia dysfunction as opposed to
other conditions with nondystonic opisthotonus.
Conclusion
We identified dystonic opisthotonus as a characteris-
tic feature of NBIAs related to PANK2 and PLA2G6
mutations and suggest that this feature, together with
other “red flags” for NBIAs (such as severe oromandib-
ular dystonia) should raise suspicion to test for these
disorders in patients with young-onset, complicated
dystonia syndromes. Hence, these patients should have
appropriate imaging, which includes T2* and suscepti-
bility-weighted imaging to look for brain iron accumu-
lation. Phenotypic “red flags” are important for
clinicians for many reasons. First, some patients with
NBIAs may not initially have evidence of iron accumu-
lation in brain imaging (as in Patients 3 and 4 presented
here), and suspicion for genetic testing can be mainly
guided by phenotypic clues; otherwise, misdiagnosis for
many years may occur.31,51 Second, the identification of
these patients may have important management impli-
cations in view of current research on new treatment
approaches.49,52 The true prevalence of this feature in
NBIAs, along with other disorders described here, needs
to be evaluated in larger studies.
TABLE 1. The differential diagnosis of dystonic opisthoto-
nus (incomplete list)
Differential diagnosis of
dystonic opisthotonus Further clues for the differential diagnosis
Drug-induced dystonia23,28,53 Often also retrocollis
History of drug consume
NBIAs Oromandibular dystonia
Parkinsonism
Iron accumulation in brain MRI
Glutaric aciduria36,40 Consanguinity
Maple syrup urine
disease35,37,38
Perinatal history
Very early age at onset
Possibly delayed motor milestones
Truncal hypotonia
Encephalopathic crisis
Intermittent painful dystonic posturing
exacerbated by fever, infections
Wilson’s disease Kayser-Fleischer rings
Oromandibular dystonia
Wing-beating tremor
Lesch-Nyhan54 Oromandibular dystonia
Self-injurious behavior
Intellectual disability
Dopa-responsive dystonia
(DYT5)33
Levodopa response
Perinatal history
Delayed motor milestones
Tyrosine hydroxylase
deficiency
Oculogyric crisis
Aromatic L-amino acid
decarboxylase deficiency
Perinatal history
Delayed motor milestones
Sepiapterin reductase
deficiency55
Primary extensor truncal
dystonia26
No further signs
Others (eg, meningitis,
encephalitis, etc)
Dependent on the underlying cause
MRI, magnetic resonance imaging; NBIAs, neurodegeneration with brain
iron accumulation syndromes.
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Legend to the Video
Video 1. Four patients with NBIAs and dystonic
opisthotonus are shown. None of the patients were
receiving neuroleptics before the onset of dystonic
opisthotonus.
Segment 1. This Indian man aged 39 years carries
homozygous mutations (c.1010A>C; p.Asp337Ala) in
the PANK2 gene. He developed decrease in visual acu-
ity and dysarthria at age 12 years and lower limb dys-
tonia and dystonic opisthotonus at age 14 years. On
examination at age 34 years, he had reduced visual
acuity, slow and hypometric vertical and horizontal
saccades, generalized dystonia with prominent oro-
mandibular dystonia, and severe dystonic opisthoto-
nus, which was more evident while walking. Brain
MRI revealed an “eye-of-the-tiger” sign.21
Segment 2. This Indian woman aged 36 years (the
sister of patient 1) carries the same mutation. At age
13 years, she developed visual disturbances, dysarthia,
and writer’s cramp on the right.21 On examination at
age 36 years, she was anarthric, and she had reduced
visual acuity and pigmentary retinopathy with hypo-
metric saccades; she also had generalized dystonia
with oromandibular involvement, retrocollis, and dys-
tonic opisthotonus with increased tone in all limbs.
Brain MRI revealed an “eye-of-the-tiger” sign.
Segment 3. This Pakistani man aged 21 years, the
product of double consanguinity, carries homozygous
c.2239C_T (p.R747W) mutations in the PLA2G6
gene.5 At age 18 years, he developed foot dystonia,
cognitive decline, and personality changes. On exami-
nation at age 21 years, he had blepharoclonus, jerky
saccadic pursuit, and asymmetric pyramidal features
with spasticity, hyper-reflexia, and rigidity; bradykine-
sia; foot dystonia; and marked opisthotonus, which
worsened with walking. Brain MRI revealed no iron
deposition on T2* imaging.
Segment 4. This Taiwanese woman aged 25 years
caries a compound heterozygous mutation of the
PLA2G6 gene (p.Asp331Tyr/p.Met358IlefsX). She
noticed unsteady gait and easy falls at age 8 years,
developed cognitive decline at age 18 years, and devel-
oped dystonia at age 22 years. Examination at age 25
years revealed retrocollis and dystonic opisthotonus
induced by walking, parkinsonism, ataxic gait, intel-
lectual impairment, and dysarthria. Brain MRI
revealed cortical and cerebellar atrophy but no evi-
dence of iron deposition on T2* sequences.22
Acknowledgments: We thank the patients for their consent to
publish the video.
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